Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(29%)
Results Posted
25%(1 trials)

Phase Distribution

Ph not_applicable
5
71%
Ph phase_2
2
29%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
2(28.6%)
N/ANon-phased studies
5(71.4%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(4)

Detailed Status

Completed4
Recruiting2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (28.6%)
N/A5 (71.4%)

Trials by Status

recruiting229%
completed457%
not_yet_recruiting114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
7